Cellular immune response – Page 15 – Communicable Diseases Research

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

증상이 있는 SARS-CoV-2 알파 감염이 있는 백신 접종 환자의 적응 면역 반응

Article

Published on 2022-03-082022-09-11
Journal: JCI Insight [Category] MERS, SARS, 변종, 진단,

Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study

종단 관찰 연구에서 BNT162b2 2회 투여 후 의료 종사자의 면역 반응 지속

Observational Study

Published on 2022-03-042022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 임상, 진단, 치료기술,

[키워드] age All participants Analysis antibody average binding binding antibody BNT162b2 BNT162b2 vaccine booster dose booster doses booster vaccinations Care cellular Cellular immune response Course COVID-19 disease declining described detectable dose Efficacy evaluated Follow-up groups Health Health care Health care worker hospital humoral humoral and cellular immunity humoral immune response immune response immunological Immunological memory individual interferon Interferon-gamma longitudinal mRNA mRNA-based vaccine Neutralizing antibodies obesity observational study of BNT162b2 Older age participant Participants peptide peptides persistence Pfizer Quantitative response response rate resulting SARS-CoV-2 SARS-COV-2 infection second dose semi-quantitative Serological testing shown vaccination Vaccine worker
[DOI] 10.3389/fimmu.2022.839922 PMC 바로가기 [Article Type] Observational Study

A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant

SARS-CoV-2 Omicron VOC에 대한 체액 및 세포 반응에 대한 증거와 이 변이체에 대한 백신 효능에 대한 표 요약

Review

Published on 2022-03-012022-09-11
Journal: Immunology letters [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 appear appearance article B.1.1.529 bioRxiv Booster vaccine carried Cellular immune response cellular response coronavirus COVID-19 databases distribution dose Effectiveness Efficacy Evidence forms health authorities Health authority humoral humoral immune response Humoral response Immune escape immune system individual ineffectiveness infections medRxiv Mutation Neutralizing antibodies omicron preserved provided responsible SARS-CoV-2 severe acute respiratory syndrome Coronavirus solution South Africa SRAS-CoV-2 symptomatic the SARS-CoV-2 These data Transmission vaccination Vaccine Vaccine against COVID-19. variant variants virus VoC
[DOI] 10.1016/j.imlet.2022.02.002 PMC 바로가기 [Article Type] Review

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong

홍콩 백신 중 우려되는 SARS-CoV-2 변종에 대한 면역 반응 약화

Article

Published on 2022-03-012022-09-11
Journal: EBioMedicine [Category] MERS, SARS, 변종, 진단, 치료기술, 치료법,

[키워드] Against AIDS B.1.1.529 B.1.617.2 BNT162b2 Breakthrough infection CD4 CD8 Cell Cellular immune response China Commission CoronaVac Council Delta Detection limit development dose dropped education Faculty of Medicine Frequency Friend friends geometric geometric mean higher risk Hong Kong Hope humoral immune response IFN-γ immune immune response immunogenicity Inactivated vaccine induce Innovation investigated matching median memory T memory T cell mRNA mRNA vaccine NAb nAb response NAbs neutralizing antibody nucleocapsid nucleocapsid protein omicron pandemic Program reactive reduced response rates responses SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Science Shenzhen significantly significantly lower Standard subset supported T cell T cell response T cells technology vaccination Vaccinations Vaccine Vaccine-induced immunity vaccinee vaccinees VoC VOCs Wellcome Trust
[DOI] 10.1016/j.ebiom.2022.103904 PMC 바로가기 [Article Type] Article

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine

코로나19 백신을 이용한 이종 프라임-부스트 면역의 반응원성과 면역원성

Review

Published on 2022-03-012022-09-11
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 임상,

[키워드] adverse events bioRxiv Cellular immune response Characteristics clinical trial clinical trials Cochrane Library COVID-19 COVID-19 vaccination database delta variant evaluated Evidence Final Heterologous heterologous prime-boost heterologous prime-boost immunization heterologous vaccination regimen heterologous vaccination regimens humoral immune response immunogenic immunogenicity Inactivated vaccine instrument medRxiv mRNA mRNA-based vaccine New observational studies outcome pandemic Prime-boost provided reactogenicity regimen risk Risk of bias robust searched selected Support systemic reactions Systemic review tolerable vaccination Vaccine vaccine administration variant with COVID-19
[DOI] 10.1016/j.biopha.2022.112650 PMC 바로가기 [Article Type] Review

Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis

유지 투석을 받는 환자에서 상동 mRNA 기반 및 벡터 기반 SARS-CoV-2 백신 요법의 면역원성과 반응성

Article

Published on 2022-03-012022-09-12
Journal: Clinical immunology (Orlando, Fla.) [Category] COVID19(2023년), MERS, SARS, 진단,

Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments

면역 조절 치료를 받는 다발성 경화증 환자 및 NMOSD 환자에서 SARS CoV-2 예방 접종에 대한 체액 및 세포 면역 반응

Observational Study

Published on 2022-03-012022-09-12
Journal: Multiple sclerosis and related disorders [Category] MERS, 임상, 진단,

Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

Contents

Published on 2022-02-282022-10-28
Journal: Obstetrics and gynecology [Category] COVID-19, COVID19(2023년), SARS,

[키워드] acute respiratory syndrome Anti-RBD antibody anti-RBD IgA Anti-RBD IgG antibody B.1.1.7 B.1.351 Beta Blood Breast breast milk Breastfeeding Cellular immune response cohort study collected controls coronavirus coronavirus disease correlated COVID-19 COVID-19 vaccination Cutoff cytokine D614G domain Dried blood spots driven by enrolled enzyme-linked immunosorbent evaluate expressed first dose Gamma IgG immune response Immunoglobulin Infant Infants interferon-γ lactating women Level milk mother mRNA mRNA-based mRNA-based COVID-19 vaccine mRNA-based vaccine neutralize neutralized neutralizing antibody P.1 passive immunity positive provided RBD reflected SARS-CoV-2 second dose second vaccination Side effects Stool Stool sample tested transfer transferred vaccination Vaccine variant variants of concern were measured were used women
[DOI] 10.1097/AOG.0000000000004661 PMC 바로가기 [Article Type] Contents

Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study

혈액 투석을받는 환자

Report

Published on 2022-02-282022-09-01
Journal: Renal failure [Category] COVID19(2023년), SARS, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults All participants ANOVA antibody both groups Cellular immune response cellular immunity comparable Control coronavirus coronavirus disease COVID-19 COVID-19 diagnosis declined disease onset evaluated General population greater HD group Hemodialysis humoral IgG IgG level IgG levels immune responses increased risk individual Infection Kidney disease Kidney function magnitude maintain Maintenance hemodialysis Mortality participant Patient patients treated prospective cohort study quantified receiving remained respiratory Result SARS-CoV-2 SARS-CoV-2 antibody seropositive Seropositivity severe acute respiratory syndrome Coronavirus significantly lower Specific T-cell response study period subgroup of patients T-cell Response T-cell responses
[DOI] 10.1080/0886022X.2022.2042310 PMC 바로가기 [Article Type] Report

DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice

엔벨로프 및 막 단백질을 발현하는 DNA 백신은 생쥐에서 SARS-CoV-2에 대한 부분적 보호를 제공합니다

Article

Published on 2022-02-242022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Against caused cellular Cellular immune response cellular response conserved coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cross-protective DNA DNA vaccine dose effective Electroporation elicited envelope envelope protein Epitopes humoral Humoral immunity Humoral response immune responses immunisation International Intramuscular injection lung tissue membrane membrane protein mice pandemic Partial protection Protein provided public health emergency respiratory robust SARS-CoV SARS-CoV-2 severe acute respiratory syndrome Coronavirus Significant structural protein structural proteins T-cell epitope target titre Vaccination strategies Vaccination strategy Vaccine vaccine candidate vaccine candidates Vaccines virus
[DOI] 10.3389/fimmu.2022.827605 PMC 바로가기 [Article Type] Article